Population Health Research Institute
Study List

FONDA-CABG (Ongoing) 
FONDAparinux to Prevent Thrombotic Complications & Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery

< back

A pilot study to demonstrate the feasibility of recruiting patients into this study and of performing CT angiograms to measure graft patency at 30 days. Our pilot study will provide key information about feasibility that will help us to design and perform a large definitive study in the future.

Study Design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy.

Intervention: Fondaparinux, Heparin.

Length of Study: 2 years

# of Patients: 50

Patient Populations: Coronary Bypass Graft Failure/Occlusion.


Available upon study completion.

Main Publications (for a full listing of publications, please visit the 'Media and Publications' section)

Not available at this time.

Print    Email
Population Health Research Institute • Hamilton, Ontario • information@phri.ca